vs

Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and ROYAL GOLD INC (RGLD). Click either name above to swap in a different company.

P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $375.3M, roughly 1.0× ROYAL GOLD INC). ROYAL GOLD INC runs the higher net margin — 24.9% vs -19.6%, a 44.6% gap on every dollar of revenue. On growth, ROYAL GOLD INC posted the faster year-over-year revenue change (85.3% vs 3.8%). Over the past eight quarters, ROYAL GOLD INC's revenue compounded faster (58.8% CAGR vs -0.5%).

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

Royal Gold Inc. is a leading precious metals streaming and royalty firm that acquires and manages a diversified portfolio of streaming interests, royalties, and equity interests tied to mining projects. Its assets cover gold, silver, and copper production across North America, South America, Africa, and Australia, operating with a low-risk model that avoids direct mining operations.

PIII vs RGLD — Head-to-Head

Bigger by revenue
PIII
PIII
1.0× larger
PIII
$384.8M
$375.3M
RGLD
Growing faster (revenue YoY)
RGLD
RGLD
+81.5% gap
RGLD
85.3%
3.8%
PIII
Higher net margin
RGLD
RGLD
44.6% more per $
RGLD
24.9%
-19.6%
PIII
Faster 2-yr revenue CAGR
RGLD
RGLD
Annualised
RGLD
58.8%
-0.5%
PIII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PIII
PIII
RGLD
RGLD
Revenue
$384.8M
$375.3M
Net Profit
$-75.5M
$93.6M
Gross Margin
64.6%
Operating Margin
-40.0%
56.2%
Net Margin
-19.6%
24.9%
Revenue YoY
3.8%
85.3%
Net Profit YoY
-28.8%
-12.8%
EPS (diluted)
$-23.08
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PIII
PIII
RGLD
RGLD
Q4 25
$384.8M
$375.3M
Q3 25
$345.3M
$252.1M
Q2 25
$355.8M
$209.6M
Q1 25
$373.2M
$193.4M
Q4 24
$370.7M
$202.6M
Q3 24
$362.1M
$193.8M
Q2 24
$379.2M
$174.1M
Q1 24
$388.5M
$148.9M
Net Profit
PIII
PIII
RGLD
RGLD
Q4 25
$-75.5M
$93.6M
Q3 25
$-31.6M
$126.8M
Q2 25
$-20.4M
$132.3M
Q1 25
$-20.5M
$113.5M
Q4 24
$-58.6M
$107.4M
Q3 24
$-46.5M
$96.2M
Q2 24
$-12.0M
$81.2M
Q1 24
$-18.7M
$47.2M
Gross Margin
PIII
PIII
RGLD
RGLD
Q4 25
64.6%
Q3 25
73.6%
Q2 25
72.6%
Q1 25
69.4%
Q4 24
70.3%
Q3 24
66.6%
Q2 24
64.7%
Q1 24
58.4%
Operating Margin
PIII
PIII
RGLD
RGLD
Q4 25
-40.0%
56.2%
Q3 25
-12.8%
64.4%
Q2 25
-9.6%
67.7%
Q1 25
-10.2%
63.6%
Q4 24
-37.4%
65.9%
Q3 24
-29.5%
61.3%
Q2 24
-8.3%
58.6%
Q1 24
-11.3%
50.7%
Net Margin
PIII
PIII
RGLD
RGLD
Q4 25
-19.6%
24.9%
Q3 25
-9.1%
50.3%
Q2 25
-5.7%
63.1%
Q1 25
-5.5%
58.7%
Q4 24
-15.8%
53.0%
Q3 24
-12.8%
49.7%
Q2 24
-3.2%
46.6%
Q1 24
-4.8%
31.7%
EPS (diluted)
PIII
PIII
RGLD
RGLD
Q4 25
$-23.08
$1.04
Q3 25
$-9.67
$1.92
Q2 25
$-6.23
$2.01
Q1 25
$-6.28
$1.72
Q4 24
$-23.13
$1.63
Q3 24
$-15.70
$1.46
Q2 24
$-7.37
$1.23
Q1 24
$-7.86
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PIII
PIII
RGLD
RGLD
Cash + ST InvestmentsLiquidity on hand
$25.0M
$233.7M
Total DebtLower is stronger
$228.4M
Stockholders' EquityBook value
$-155.2M
$7.2B
Total Assets
$656.6M
$9.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PIII
PIII
RGLD
RGLD
Q4 25
$25.0M
$233.7M
Q3 25
$37.7M
$172.8M
Q2 25
$38.6M
$248.2M
Q1 25
$40.1M
$240.8M
Q4 24
$38.8M
$195.5M
Q3 24
$63.0M
$127.9M
Q2 24
$73.1M
$74.2M
Q1 24
$27.3M
$137.9M
Total Debt
PIII
PIII
RGLD
RGLD
Q4 25
$228.4M
Q3 25
$252.8M
Q2 25
$182.0M
Q1 25
$171.1M
Q4 24
$108.9M
Q3 24
$133.2M
$0
Q2 24
$133.1M
$50.0M
Q1 24
$118.1M
Stockholders' Equity
PIII
PIII
RGLD
RGLD
Q4 25
$-155.2M
$7.2B
Q3 25
$-18.7M
$3.4B
Q2 25
$44.5M
$3.3B
Q1 25
$63.3M
$3.2B
Q4 24
$75.9M
$3.1B
Q3 24
$120.5M
$3.0B
Q2 24
$166.8M
$3.0B
Q1 24
$146.6M
$2.9B
Total Assets
PIII
PIII
RGLD
RGLD
Q4 25
$656.6M
$9.5B
Q3 25
$683.6M
$4.5B
Q2 25
$731.6M
$3.6B
Q1 25
$783.9M
$3.5B
Q4 24
$783.4M
$3.4B
Q3 24
$833.3M
$3.3B
Q2 24
$892.8M
$3.3B
Q1 24
$855.9M
$3.3B
Debt / Equity
PIII
PIII
RGLD
RGLD
Q4 25
Q3 25
Q2 25
4.09×
Q1 25
2.71×
Q4 24
1.43×
Q3 24
1.11×
0.00×
Q2 24
0.80×
0.02×
Q1 24
0.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PIII
PIII
RGLD
RGLD
Operating Cash FlowLast quarter
$-25.7M
$241.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PIII
PIII
RGLD
RGLD
Q4 25
$-25.7M
$241.7M
Q3 25
$-15.4M
$174.0M
Q2 25
$-16.6M
$152.8M
Q1 25
$-33.5M
$136.4M
Q4 24
$-57.2M
$141.1M
Q3 24
$-22.6M
$136.7M
Q2 24
$-10.2M
$113.5M
Q1 24
$-20.0M
$138.3M
Capex Intensity
PIII
PIII
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
PIII
PIII
RGLD
RGLD
Q4 25
2.58×
Q3 25
1.37×
Q2 25
1.15×
Q1 25
1.20×
Q4 24
1.31×
Q3 24
1.42×
Q2 24
1.40×
Q1 24
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

RGLD
RGLD

Gold$216.9M58%
Pueblo Viejo$47.3M13%
Andacollo$32.6M9%
Silver$32.1M9%
Other$27.2M7%
Copper$13.7M4%
Cortez Legacy Zone$5.4M1%

Related Comparisons